Federal award

KBR WYLE SERVICES, LLC

W31P4Q04C0004

Contract

Obligated and Ceiling

Obligated (net): $5,285,489.51
Ceiling (potential value, not spending): $2,211,815.17
Current value: $2,211,815.17
Gross positive obligations: $10,181,768.76

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient: KBR WYLE SERVICES, LLC · PMRAPK4NLQC1
Owner company: Wyle LaboratoriesBasis direct: the recipient is the company's own reviewed UEI.
Reported parent: KBR WYLE SERVICES, LLC · TGPKTMN8YL31
Awarding agency: Department of War · sub-agency 2100 · office W31P4Q
Funding agency: Department of War · sub-agency 2100
Product or service (PSC): AD92 · R&D- DEFENSE OTHER: OTHER (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS): 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
PIID: W31P4Q04C0004
Award type code: D
Actions: 59 · Oct 29, 2007 to Aug 15, 2024
Why it is listed: gross positive obligations of $100k or more (contracts); reviewed company, $10k or more

Open this award on USAspending →

Action History59

Award actions
Date	FY	Mod	Action type	Obligation	Company in company totals
Aug 15, 2024	FY2024	P00165	M	−$1,256.28	Wyle Laboratories
Jun 27, 2023	FY2023	P00164	M	−$5,953.88	Wyle Laboratories
Jun 27, 2023	FY2023	P00164	M	−$21,474.64	Wyle Laboratories
Jul 27, 2022	FY2022	P00163	M	−$329.80	KBR Counted for KBR in company totals (reported by USAspending)
Sep 21, 2020	FY2020	P00162	C	−$17.05	KBR Counted for KBR in company totals (reported by USAspending)
Dec 5, 2014	FY2015	P00160	C	−$49,070.21	Wyle Laboratories
Dec 5, 2014	FY2015	P00160	C	−$731,959.43	Wyle Laboratories
Jun 7, 2013	FY2013	P00159	B	−$31,450.77	Wyle Laboratories
Aug 29, 2012	FY2012	P00158	B	−$801.20	Wyle Laboratories
Jun 14, 2012	FY2012	P00157	C	−$11.93	Wyle Laboratories
Jun 14, 2012	FY2012	P00157	C	−$19,926.60	Wyle Laboratories
Sep 28, 2011	FY2011	P00156	C	−$2,486.26	Wyle Laboratories
Jul 27, 2011	FY2011	P00155	C	−$38,701.26	Wyle Laboratories
Apr 26, 2011	FY2011	P00154	C	−$15,411.66	Wyle Laboratories
Apr 21, 2011	FY2011	P00153	C	−$6,069.19	Wyle Laboratories
Apr 18, 2011	FY2011	P00152	C	−$96,795.20	Wyle Laboratories
Apr 11, 2011	FY2011	P00151	D	−$1,262.22	Wyle Laboratories
Dec 29, 2010	FY2011	P00150	C	−$64,576.09	Wyle Laboratories
Nov 9, 2010	FY2011	P00149	D	−$4,134.27	Wyle Laboratories
Oct 6, 2010	FY2011	P00148	M	−$85,852.24	Wyle Laboratories
Jun 22, 2010	FY2010	P00147	C	−$188.06	Wyle Laboratories
Mar 2, 2010	FY2010	P00146	M	−$327,335.77	Wyle Laboratories
Sep 30, 2009	FY2009	P00145	D	−$87,975.27	Wyle Laboratories
Sep 1, 2009	FY2009	P00144	B	−$854,100.15	Wyle Laboratories
Sep 1, 2009	FY2009	P00144	B	−$853,016.58	Wyle Laboratories
Mar 12, 2009	FY2009	P00143	B	−$25,000.00	Wyle Laboratories
Mar 12, 2009	FY2009	P00143	B	−$1,444,113.88	Wyle Laboratories
Oct 29, 2008	FY2009	P00142	B	$0.00	Wyle Laboratories
Sep 29, 2008	FY2008	P00141	M	$0.00	Wyle Laboratories
Sep 10, 2008	FY2008	P00140	G	$80,999.00	Wyle Laboratories
Jul 25, 2008	FY2008	P00139	G	$6,767.20	Wyle Laboratories
Jul 22, 2008	FY2008	P00138	M	−$62,671.64	Wyle Laboratories
Jun 16, 2008	FY2008	P00137	G	$240,652.44	Wyle Laboratories
Jun 9, 2008	FY2008	P00136	G	$207,624.16	Wyle Laboratories
May 30, 2008	FY2008	P00135	G	$868,561.80	Wyle Laboratories
May 20, 2008	FY2008	P00134	M	$0.00	Wyle Laboratories
May 12, 2008	FY2008	P00133	G	$3,859.68	Wyle Laboratories
May 12, 2008	FY2008	P00133	G	−$0.20	Wyle Laboratories
Apr 14, 2008	FY2008	P00132	G	$35,660.70	Wyle Laboratories
Apr 14, 2008	FY2008	P00132	G	−$64,337.52	Wyle Laboratories
Apr 2, 2008	FY2008	P00131	G	$0.00	Wyle Laboratories
Mar 20, 2008	FY2008	P00130	G	$90,974.60	Wyle Laboratories
Mar 20, 2008	FY2008	P00130	G	$117,182.70	Wyle Laboratories
Mar 11, 2008	FY2008	P00129	M	$0.00	Wyle Laboratories
Feb 28, 2008	FY2008	P00128	G	$4,274,162.69	Wyle Laboratories
Feb 28, 2008	FY2008	P00128	G	$559,173.89	Wyle Laboratories
Feb 13, 2008	FY2008	P00127	M	$0.00	Wyle Laboratories
Feb 7, 2008	FY2008	P00126	G	$189,807.38	Wyle Laboratories
Feb 4, 2008	FY2008	P00125	M	$0.00	Wyle Laboratories
Jan 31, 2008	FY2008	P00124	G	$1,403,268.72	Wyle Laboratories
Jan 31, 2008	FY2008	P00124	G	$1,395,386.90	Wyle Laboratories
Jan 23, 2008	FY2008	P00123	M	$0.00	Wyle Laboratories
Jan 3, 2008	FY2008	P00122	G	$84,306.00	Wyle Laboratories
Dec 12, 2007	FY2008	P00121	M	$0.00	Wyle Laboratories
Dec 4, 2007	FY2008	P00120	G	$17,657.00	Wyle Laboratories
Dec 4, 2007	FY2008	P00120	G	$14,000.00	Wyle Laboratories
Nov 1, 2007	FY2008	P00119	M	$0.00	Wyle Laboratories
Oct 29, 2007	FY2008	P00118	B	$117,287.50	Wyle Laboratories
Oct 29, 2007	FY2008	P00118	B	$474,436.40	Wyle Laboratories

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.